Clinical Trial Update: Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of gemcitabine and cisplatin in patients with inoperable biliary tract carcinomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Biliary Tract Carcinoma | Phase 2 | Status: COMPLETED